174 Followers on Owler
OverviewCompetitorsAcquisitionsFundingNews & Insights

Grunenthal Competitors or Alternatives

Grunenthal's top competitors include Endo, UCB and Salix Pharmaceuticals.

Unlock 11 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Grunenthal's company profile

Gabriel Baertschi

Chairman & CEO

80/100
1,000 - 5,000
$852.9M
$1B - 5B
  • $852.9M
    $1B - 5B
  • 1,000 - 5,000
    $852.9M
  • $1B - 5B
  • 80/100
  • 1,000 - 5,000
  • $852.9M
  • $1B - 5B
View ProfileView
1
Grunenthal's Competitor - Endo logo

Scott Hirsch

Interim-CEO

- -
3,116
$2.9B
$1.2B
  • $2.9B
    $1.2B
  • 3,116
    $2.9B
  • $1.2B
  • - -
  • 3,116
  • $2.9B
  • $1.2B
View ProfileView
2
Grunenthal's Competitor - UCB logo

Jean-Christophe Tellier

Chairman & CEO

93/100
9,083
- -
$5.8B
  • - -
    $5.8B
  • 9,083
    - -
  • $5.8B
  • 93/100
  • 9,083
  • - -
  • $5.8B
View ProfileView
3
Grunenthal's Competitor - Salix Pharmaceuticals logo

Robert Spurr

President

82/100
500 - 1,000
$60M
$1B - 5B
  • $60M
    $1B - 5B
  • 500 - 1,000
    $60M
  • $1B - 5B
  • 82/100
  • 500 - 1,000
  • $60M
  • $1B - 5B
View ProfileView
4
Grunenthal's Competitor - AbbVie logo

Robert A. Michael

CEO

81/100
50,000
$6B
$56.3B
  • $6B
    $56.3B
  • 50,000
    $6B
  • $56.3B
  • 81/100
  • 50,000
  • $6B
  • $56.3B
View ProfileView
5
Grunenthal's Competitor - Zogenix logo

Stephen J. Farr

President & CEO

84/100
250 - 500
$494.3M
$25M - 100M
  • $494.3M
    $25M - 100M
  • 250 - 500
    $494.3M
  • $25M - 100M
  • 84/100
  • 250 - 500
  • $494.3M
  • $25M - 100M
View ProfileView
Grunenthal's top 14 competitors are Endo, UCB, Salix Pharmaceuticals, Takeda Pharmaceutical, AbbVie, Zogenix, Viatris, Jazz Pharmaceuticals, Acorda, Sentynl Therapeutics, Mylan, TEVA, Umar Pharma and Impax Laboratories, Llc. Together they have raised over 40.6B between their estimated 228.7K employees. Grunenthal's revenue is the ranked 9th among it's top 10 competitors. The top 10 competitors average 9.7B. Grunenthal has 4,400 employees and is ranked 7th among it's top 10 competitors. The top 10 competitors average 15,542.

Grunenthal VS Endo

Endo is one of Grunenthal's top competitors. Endo was founded in 1997 in Malvern, Pennsylvania. Like Grunenthal, Endo also operates in the Pharmaceuticals industry. Endo generates $821.8M less revenue than Grunenthal.

Grunenthal VS UCB

UCB is a top competitor of Grunenthal. UCB was founded in 1928, and is headquartered in Brussels, Brussels-Capital Region. Like Grunenthal, UCB also competes in the Pharmaceuticals field. UCB generates $3.8B more revenue vs. Grunenthal.

Looking for similar companies to Grunenthal?

Similar Companies

Pharmaceuticals companies in Aachen

See 11 companies 
Companies in North Rhine-Westphalia with revenue in $1.0-5.0B range

See 83 companies 
Pharmaceuticals & Biotechnology companies in Aachen

See 19 companies 
Pharmaceuticals companies in North Rhine-Westphalia

See 106 companies 
Pharmaceuticals companies with revenue in $1.0-5.0B range

See 144 companies 
Companies in North Rhine-Westphalia with employees in 1.0-5.0K range

See 149 companies 
Pharmaceuticals & Biotechnology companies in North Rhine-Westphalia

See 167 companies 
Pharmaceuticals & Biotechnology companies with revenue in $1.0-5.0B range

See 192 companies 
Pharmaceuticals companies with employees in 1.0-5.0K range

See 203 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for Grunenthal and Grunenthal's Competitors

March 31, 2025centralcharts
Regulatory News: Medincell (Paris:MEDCL): More than 92% of schizophrenia patients taking Olanzapine LAI in the Phase 3 SOLARIS survey were satisfied or...
March 31, 2025Seeking Alpha
March 30, 2025centralcharts
New York, New York--(Newsfile Corp. - March 30, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential secu...
March 31, 2025Openpr
The latest release from Coherent Market Insights, titled "Silicone Elastomers Market Research Report 2025-2032", provides an in-depth assessment of the...
March 31, 2025PR Newswire
/PRNewswire/ -- AbbVie (NYSE: ABBV) will announce its first-quarter 2025 financial results on Friday, April 25, 2025, before the market opens. AbbVie w...

Frequently Asked Questions about Grunenthal

  1. Who are Grunenthal's top competitors?

    Grunenthal's top 3 competitors are Endo, UCB, Salix Pharmaceuticals.

  2. Who is similar to Grunenthal?

    Endo is the most similar to Grunenthal. UCB and Salix Pharmaceuticals are also similar to Grunenthal.

  1. Are Grunenthal and Endo competitors?

    Yes, Endo is one of Grunenthal’s top competitors.